SOUTH KOREA · OPENDART
ToolGen Incorporated
툴젠 · 199800 · KOSDAQ · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insider timeline
2 insiders bought in the last 180 days, 1 of them more than once.
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
×A sale
A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.
Blue line: this share's price, −70.1% over these six months
The closing price of each day, from 99,900.00 on 2026-04-21 to 29,850.00 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −31.9%
Taken from the 1525 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −70.1%, the typical one −31.9%, 38.3 points behind. It is not an index and not a comparison within one industry.
This company: insiders buying per month, last 12 months
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| KWON SOON IL | Executive | — | 1 | — | — | — |
| Ryu Jong Sang | CEO / chair | 2 | — | 18.1M KRW | 2026-07-06 | −15.4% |
| Hyun Soon Cho | Executive | 1 | — | 10.5M KRW | 2026-09-03 | −10.6% |
Purchases against sales
Shares of the reported value of insider transactions in the 180-day window. Sales include disposals for tax, at option exercise or under a pre-set plan, which say little about an insider's view. The split describes what was disclosed; it is not a signal.
Insiders' buying price vs the latest close
Insiders paid 38,013.00 KRW a share on average (3 purchase lines, 2 buyers, 2026-07-06 – 2026-09-03). The close on 2026-10-16 was 21.5% below that price.
The latest purchase (2026-09-03) was at 34,860.00 KRW; the close was 14.4% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Hyun Soon Cho | Senior managing director | Bought on the exchange | 300 | ₩34,860 | ₩10.5M | DART ↗ |
| 2026-07-27 | Ryu Jong Sang | CEO | Bought on the exchange | 200 | ₩45,150 | ₩9.0M | DART ↗ |
| 2026-07-06 | Ryu Jong Sang | CEO | Bought on the exchange | 250 | ₩36,087 | ₩9.0M | DART ↗ |
| 2026-04-27 | KWON SOON IL | Managing director | Sold on the exchange | 600 | ₩90,317 | ₩54.2M | DART ↗ |
| 2026-01-07 | KWON SOON IL | Managing director | Sold on the exchange | 1,500 | ₩59,106 | ₩88.7M | DART ↗ |
Other changes in holdings · 17
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.
| Date | Insider | Role | Reason | Shares | Filing |
|---|---|---|---|---|---|
| 2026-09-29 | Genexine, Inc | 10% shareholder | Others(-) | 9,660 | DART ↗ |
| 2026-09-29 | Genexine, Inc | 10% shareholder | Acquisition of paid-in new shares(+) | 9,660 | DART ↗ |
| 2026-09-29 | JO JUNE SUNG | Managing director | Others(-) | 8 | DART ↗ |
| 2026-09-29 | JO JUNE SUNG | Managing director | Acquisition of paid-in new shares(+) | 8 | DART ↗ |
| 2026-09-29 | KWON SOON IL | Managing director | Others(-) | 363 | DART ↗ |
| 2026-09-29 | KWON SOON IL | Managing director | Acquisition of paid-in new shares(+) | 412 | DART ↗ |
| 2026-09-29 | Ryu Jong Sang | CEO | Others(-) | 38 | DART ↗ |
| 2026-09-29 | Ryu Jong Sang | CEO | Acquisition of paid-in new shares(+) | 42 | DART ↗ |
| 2026-08-31 | Genexine, Inc | 10% shareholder | Disposal in OTC(-) | 86,942 | DART ↗ |
| 2026-08-25 | Genexine, Inc | 10% shareholder | Others(+) | 96,602 | DART ↗ |
| 2026-08-25 | JO JUNE SUNG | Managing director | Others(+) | 8 | DART ↗ |
| 2026-08-25 | KWON SOON IL | Managing director | Others(+) | 363 | DART ↗ |
| 2026-08-25 | Ryu Jong Sang | CEO | Others(+) | 38 | DART ↗ |
| 2026-04-30 | KWON SOON IL | Managing director | Others(+) | 1,235 | DART ↗ |
| 2026-03-31 | Kim Jin Soo | Non-executive director | Executive retirement(-) | 595,144 | DART ↗ |
| 2025-09-15 | Kim Jin Soo | Non-executive director | Others(-) | 85,000 | DART ↗ |
| 2024-12-27 | Kim Jin Soo | Non-executive director | 신규선임(+) | 680,144 | DART ↗ |